| Original language | English (US) |
|---|---|
| Number of pages | 1 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology |
| Volume | 30 |
| Issue number | 11 |
| DOIs |
|
| State | Published - Nov 1 2019 |
ASJC Scopus subject areas
- Hematology
- Oncology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, No. 11, 01.11.2019.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Erratum
T2 - Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study (Annals of oncology : official journal of the European Society for Medical Oncology (2017) 28 7 (1631-1639))
AU - Long, G. V.
AU - Flaherty, K. T.
AU - Stroyakovskiy, D.
AU - Gogas, H.
AU - Levchenko, E.
AU - de Braud, F.
AU - Larkin, J.
AU - Garbe, C.
AU - Jouary, T.
AU - Hauschild, A.
AU - Chiarion-Sileni, V.
AU - Lebbe, C.
AU - Mandalá, M.
AU - Millward, M.
AU - Arance, A.
AU - Bondarenko, I.
AU - Haanen, J. B.A.G.
AU - Hansson, J.
AU - Utikal, J.
AU - Ferraresi, V.
AU - Mohr, P.
AU - Probachai, V.
AU - Schadendorf, D.
AU - Nathan, P.
AU - Robert, C.
AU - Ribas, A.
AU - Davies, M. A.
AU - Lane, S. R.
AU - Legos, J. J.
AU - Mookerjee, B.
AU - Grob, J. J.
PY - 2019/11/1
Y1 - 2019/11/1
UR - http://www.scopus.com/inward/record.url?scp=85077175829&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077175829&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdz221
DO - 10.1093/annonc/mdz221
M3 - Comment/debate
C2 - 31406976
SN - 0923-7534
VL - 30
JO - Annals of oncology : official journal of the European Society for Medical Oncology
JF - Annals of oncology : official journal of the European Society for Medical Oncology
IS - 11
ER -